GMP Bridge is a senior-only consultancy focused on solving complex GMP and Quality challenges in biopharma, biotech, and advanced therapies. We combine deep hands-on experience with pragmatic execution, helping clients address critical issues where product quality, patient safety, and regulatory credibility are at stake.

We support biopharma manufacturers, clinical-stage biotech companies, advanced therapy developers, and organizations working with CDMOs and external manufacturing partners. Our work ranges from site-level operational challenges to broader Quality and compliance transformations.

Yes. We help companies prepare for FDA and EU GMP inspections through expert assessments, mock inspections, remediation support, and leadership coaching. Our focus is not only on documentation, but on building a site and a team that can perform credibly under inspection pressure.

We do both. GMP Bridge supports clients from assessment and strategy through to hands-on implementation. This includes strengthening Quality systems, governance, training, documentation, oversight models, and the execution needed to deliver sustainable GMP improvements.

Yes. GMP Bridge is headquartered in Basel, Switzerland, and supports clients globally. We work across Europe, North America, and other international manufacturing networks, including projects involving CDMOs, suppliers, and cross-border Quality oversight.